Intelligent Bio Solutions Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company, headquartered in New York and incorporated in Delaware, submitted the request via a letter dated March 13, 2024, addressed to the SEC's Division of Corporate Finance. Intelligent Bio Solutions Inc. seeks to have the Registration Statement become effective at 4:30 P.M. Eastern Time on March 15, 2024. The request was signed by Spiro Sakiris, the Chief Financial Officer of Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company, headquartered in New York and incorporated in Delaware, submitted the request via a letter dated March 13, 2024, addressed to the SEC's Division of Corporate Finance. Intelligent Bio Solutions Inc. seeks to have the Registration Statement become effective at 4:30 P.M. Eastern Time on March 15, 2024. The request was signed by Spiro Sakiris, the Chief Financial Officer of Intelligent Bio Solutions Inc.